The Provider Perspective: Identifying Barriers to Prescribing Long Acting Injectables to Persons with Mental Illness

The Provider Perspective: Identifying Barriers to Prescribing Long Acting Injectables to Persons with Mental Illness

College

College of Health Sciences

Program

D.N.P. Nursing Practice - Advanced Practice

Publication Date

3-28-2019

Abstract

Long acting injectable (LAI) antipsychotic medications should be used as a first-line treatment when patients require long-term antipsychotic treatment. However, clinicians often decide not to prescribe these drugs. Psychiatric clinicians are positioned to create and employ change. Therefore, it is important to explore experiences and opinions influencing LAI antipsychotic medication prescribing practices to minimize barriers that impact the receipt of the best and most appropriate medications for persons with mental illnesses. This study will explore the relationship between provider sociodemographic, practice locations, behavior attitudes, industry norms, and clinician prescribing behaviors. A non-experimental cross-sectional design with prospective data collection as an anonymous on-line survey used to collect data. Identification of any correlations between the sociodemographic, contextual factors, behavior attitudes, subjective norms, perceived behavioral control, and prescribing behaviors of clinicians and plans to, or not, increase use of LAI antipsychotic medications in their practice in the following 12 months. LAI antipsychotic medications improve patient adherence to treatment, but clinicians often fail to prescribe these drugs. Providers are central to successful patient outcomes as they control which medications are prescribed. Therefore, it is critical to explore factors that influence clinicians’ decisions to prescribe LAI antipsychotic medications, creating a barrier for patient accessibility.

The Provider Perspective: Identifying Barriers to Prescribing Long Acting Injectables to Persons with Mental Illness


Share

COinS